COBAS CMV

Cytomegalovirus (cmv) Dna Quantitative Assay

FDA Premarket Approval P160041

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval of the cobas cmv test - this device is indicated for:cobas® cmv is an in vitro nucleic acid amplification test for the quantitation of cytomegalovirus (cmv) dna in human edta plasma. Cobas® cmv is intended for use as an aid in the management of cmv in solid organ transplant patients and in hematopoietic stem cell transplant patients. In patients receiving anti-cmv therapy, serial dna measurements can be used to assess viral response to treatment. The results from cobas® cmv must be interpreted within the context of all relevant clinical and laboratory findings. Cobas® cmv is not intended for use as a screening test for blood or blood products.

DeviceCOBAS CMV
Classification NameCytomegalovirus (cmv) Dna Quantitative Assay
Generic NameCytomegalovirus (cmv) Dna Quantitative Assay
ApplicantROCHE MOLECULAR SYSTEMS, INC.
Date Received2016-09-21
Decision Date2017-06-01
Notice Date2017-06-07
PMAP160041
SupplementS
Product CodePAB
Docket Number17M-3430
Advisory CommitteeMicrobiology
Expedited ReviewNo
Combination Product No
Applicant Address ROCHE MOLECULAR SYSTEMS, INC. 4300 Hacienda Drive pleasanton, CA 94588-2722
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P160041Original Filing
S035 2022-05-31 Normal 180 Day Track
S034 2021-12-20 30-day Notice
S033 2021-05-18 Special (immediate Track)
S032 2020-11-13 30-day Notice
S031 2020-09-17 Special (immediate Track)
S030 2020-07-27 30-day Notice
S029 2020-04-17 30-day Notice
S028 2020-01-10 30-day Notice
S027 2019-11-29 30-day Notice
S026 2019-09-20 30-day Notice
S025 2019-08-30 30-day Notice
S024 2019-08-06 30-day Notice
S023
S022 2019-05-09 30-day Notice
S021 2019-05-09 30-day Notice
S020 2019-04-24 30-day Notice
S019 2019-04-24 30-day Notice
S018 2019-04-10 30-day Notice
S017 2019-04-03 30-day Notice
S016 2018-12-14 30-day Notice
S015 2018-11-13 30-day Notice
S014 2018-11-09 30-day Notice
S013 2018-08-21 30-day Notice
S012 2018-07-27 30-day Notice
S011 2018-06-29 30-day Notice
S010 2018-06-08 30-day Notice
S009 2018-06-04 30-day Notice
S008 2018-04-16 30-day Notice
S007 2018-03-01 30-day Notice
S006 2018-02-22 30-day Notice
S005 2018-01-23 30-day Notice
S004 2017-11-22 30-day Notice
S003 2017-10-30 30-day Notice
S002 2017-09-26 30-day Notice
S001 2017-07-14 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.